Sequent Scientific Limited
Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was former… Read more
Sequent Scientific Limited (SEQUENT) - Total Liabilities
Latest total liabilities as of September 2025: ₹8.40 Billion INR
Based on the latest financial reports, Sequent Scientific Limited (SEQUENT) has total liabilities worth ₹8.40 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sequent Scientific Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Sequent Scientific Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sequent Scientific Limited Competitors by Total Liabilities
The table below lists competitors of Sequent Scientific Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Abacus Life Inc.
NASDAQ:ABL
|
USA | $479.34 Million |
|
Huadian Ener-B
SHG:900937
|
China | $23.81 Billion |
|
FIC Global Inc
TW:3701
|
Taiwan | NT$7.73 Billion |
|
Guangdong Weide Information Technology Co. Ltd. A
SHG:688171
|
China | CN¥72.67 Million |
|
SI-TECH Information Technology Co Ltd
SHE:300608
|
China | CN¥921.06 Million |
|
Guangdong Shunkong Development Co Ltd
SHE:003039
|
China | CN¥3.97 Billion |
|
Kempower Oyj
HE:KEMPOWR
|
Finland | €144.90 Million |
|
Greentown Management Holdings Company Limited
PINK:GRMHF
|
USA | $3.11 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down Sequent Scientific Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sequent Scientific Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sequent Scientific Limited (2006–2025)
The table below shows the annual total liabilities of Sequent Scientific Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹8.32 Billion | +0.50% |
| 2024-03-31 | ₹8.27 Billion | +6.09% |
| 2023-03-31 | ₹7.80 Billion | +9.72% |
| 2022-03-31 | ₹7.11 Billion | +15.35% |
| 2021-03-31 | ₹6.16 Billion | -15.68% |
| 2020-03-31 | ₹7.31 Billion | +14.02% |
| 2019-03-31 | ₹6.41 Billion | -2.62% |
| 2018-03-31 | ₹6.58 Billion | -27.72% |
| 2017-03-31 | ₹9.11 Billion | +56.96% |
| 2016-03-31 | ₹5.80 Billion | -13.34% |
| 2015-03-31 | ₹6.69 Billion | +19.25% |
| 2014-03-31 | ₹5.61 Billion | +15.36% |
| 2013-03-31 | ₹4.87 Billion | +16.06% |
| 2012-03-31 | ₹4.19 Billion | +33.18% |
| 2011-03-31 | ₹3.15 Billion | +16.54% |
| 2010-03-31 | ₹2.70 Billion | +25.68% |
| 2009-03-31 | ₹2.15 Billion | +400.41% |
| 2008-03-31 | ₹429.63 Million | +188.32% |
| 2007-03-31 | ₹149.01 Million | +94.73% |
| 2006-03-31 | ₹76.52 Million | -- |